Home > Insider Trading > Filing (0001104659-16-145549)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1660719	Aralez Pharmaceuticals Inc.	ARLZ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1537250	Paul Robert Harris	C/O Aralez Pharmaceuticals Inc., 7100 West Credit Avenue, Suite 101 Mississauga A6 L5N 0E4		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, Without Par Value	Disposition	2016-09-15	75,000	$5.60	669,094	No	4	S	Direct
Common Shares, Without Par Value	Disposition	2016-09-15	75,000	$6.04	594,094	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares, Without Par Value	600,188	Indirect	By spouse

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2016.
This transaction was executed in multiple trades at prices ranging from $6.00 to $6.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.